{"id":"NCT00840801","sponsor":"Pfizer","briefTitle":"Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children","officialTitle":"SINGLE-BLIND, RANDOMIZED, PHASE III B STUDY IN CHILDREN AGED 1 - 11 YEARS TO INVESTIGATE THE IMMUNOGENICITY, SAFETY AND INTERCHANGEABILITY OF TWO TICK-BORNE ENCEPHALITIS (TBE) VACCINES ADMINISTERED ACCORDING TO A CONVENTIONAL SCHEDULE","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-02-06","primaryCompletion":"2010-05-20","completion":"2010-05-20","firstPosted":"2009-02-10","resultsPosted":"2024-01-19","lastUpdate":"2024-01-19"},"enrollment":302,"design":{"allocation":"RANDOMIZED","model":null,"masking":"SINGLE","primaryPurpose":"PREVENTION"},"conditions":["Encephalitis, Tick-Borne"],"interventions":[{"type":"BIOLOGICAL","name":"Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)","otherNames":[]},{"type":"BIOLOGICAL","name":"Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"EXPERIMENTAL"}],"summary":"The objective of this study is to assess the immunogenicity, safety and interchangeability of two different TBE vaccines in children aged 1-11 years, the first and second vaccination with either FSME-IMMUN 0.25ml Junior or Encepur 0.25ml Children and the third vaccination with FSME-IMMUN 0.25 ml Junior only, administered according to the conventional schedule (0, 28 and 360 days).","primaryOutcome":{"measure":"Seropositivity Rate as Determined by Neutralization Test (NT) 28 Days After the Second Vaccination","timeFrame":"28 days after Vaccination 2","effectByArm":[{"arm":"FSME-IMMUN","deltaMin":100,"sd":null},{"arm":"Encepur","deltaMin":97.8,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"1 Year","sex":"ALL","healthyVolunteers":true,"inclusionCount":6,"exclusionCount":17},"locations":{"siteCount":8,"countries":["Austria","Czechia"]},"refs":{"pmids":[],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=700801&StudyName=Immunogenicity%2C%20safety%20and%20interchangeability%20of%20two%20tbe%20vaccines%20administered%20according%20to%20a%20conventional%20schedule%20in%20children"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":50},"commonTop":["INJECTION SITE PAIN","PYREXIA","TRACHEITIS","NASOPHARYNGITIS","TONSILLITIS"]}}